Publications by authors named "Michele di Silvestro"
Aims: Infections resulting from cardiac implantable electronic device (CIED) implantation are severely impacting on patients' and on health care systems. The use of TYRXTM absorbable antibiotic-eluting envelope has proven to decrease major CIED infections within 12 months of CIED surgery. The aim is to evaluate the impact of the envelope use on infection-related clinical events in a real-world contemporary patient population.
View Article and Find Full Text PDFArticle Synopsis
- * A total of 2,669 patients were followed for about 39 months, revealing that L-PM patients had lower device-related complications overall (0.5% vs. 1.9% at 12 months).
- * While early complication rates were similar for both types, L-PM had significantly fewer late complications, indicating it could be a safer option for patients.
Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
Catheter Cardiovasc Interv
November 2016
Objectives: We aimed at comparing the acute performance of bioresorbable scaffolds (BRS) and second-generation drug-eluting stents (DES) for the treatment of chronic total occlusions (CTO).
Background: There is a lack of knowledge regarding the use of BRS in CTO.
Methods: Key outcomes of interest were technical and procedural success.